GE HealthCare Technologies Inc. (NASDAQ:GEHC) Holdings Raised by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 14.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,785,740 shares of the company's stock after purchasing an additional 596,486 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.05% of GE HealthCare Technologies worth $374,162,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. First Trust Advisors LP increased its stake in GE HealthCare Technologies by 22.7% in the fourth quarter. First Trust Advisors LP now owns 568,569 shares of the company's stock valued at $44,451,000 after purchasing an additional 105,234 shares during the period. Epoch Investment Partners Inc. raised its stake in shares of GE HealthCare Technologies by 14.7% during the 4th quarter. Epoch Investment Partners Inc. now owns 651,838 shares of the company's stock worth $50,961,000 after buying an additional 83,730 shares in the last quarter. Forum Financial Management LP lifted its holdings in GE HealthCare Technologies by 30.7% in the fourth quarter. Forum Financial Management LP now owns 7,953 shares of the company's stock valued at $622,000 after acquiring an additional 1,869 shares during the period. Commerce Bank boosted its holdings in GE HealthCare Technologies by 184.7% during the fourth quarter. Commerce Bank now owns 53,555 shares of the company's stock worth $4,187,000 after buying an additional 34,745 shares in the last quarter. Finally, Canada Pension Plan Investment Board increased its stake in GE HealthCare Technologies by 4.8% in the 4th quarter. Canada Pension Plan Investment Board now owns 2,701,762 shares of the company's stock valued at $211,224,000 after purchasing an additional 124,651 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on GEHC shares. BTIG Research set a $95.00 target price on shares of GE HealthCare Technologies and gave the stock a "buy" rating in a research report on Monday, April 14th. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and raised their price target for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup upped their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Finally, Piper Sandler dropped their target price on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $96.50.

GE HealthCare Technologies Stock Up 5.4 %

NASDAQ:GEHC traded up $3.31 during mid-day trading on Wednesday, reaching $64.96. The stock had a trading volume of 6,291,698 shares, compared to its average volume of 3,223,787. The company has a market capitalization of $29.74 billion, a price-to-earnings ratio of 15.00, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. The stock's 50 day simple moving average is $78.12 and its two-hundred day simple moving average is $82.62. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.22%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.